| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.4 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |